Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This Phase II clinical trial is to study the effectiveness and safety of continuous hepatic
arterial infusion (HAI) of Oxaliplatin and Fluorouracil in Patients with Unresectable Biliary
tract carcinomas, and to explore a better first-line treatment regimen for these patients.